I-FABP is decreased in COVID-19 patients, independently of the prognosis

BACKGROUND: Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) is frequently associated with gastrointestinal manifestations. Herein we evaluated the interest in measuring the intestinal fatty acid-binding protein (I-FABP), a biomarker of intestinal injury, in COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Guedj, Kevin, Uzzan, Mathieu, Soudan, Damien, Trichet, Catherine, Nicoletti, Antonino, Weiss, Emmanuel, Manceau, Hana, Nuzzo, Alexandre, Corcos, Olivier, Treton, Xavier, Peoc’h, Katell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049236/
https://www.ncbi.nlm.nih.gov/pubmed/33857216
http://dx.doi.org/10.1371/journal.pone.0249799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049236/
https://www.ncbi.nlm.nih.gov/pubmed/33857216
http://dx.doi.org/10.1371/journal.pone.0249799

Ejemplares similares